InsiderDB

Rep. Lisa C. McClain bought Encompass Health (EHC)

Rep. Lisa C. McClain (R-MI-9) · $1K–$15K · traded Jul 22, 2025

Transaction
Bought
Amount
$1K–$15K
Owner
Spouse
Traded
Jul 22, 2025
Disclosed
Aug 13, 2025
Days to disclose
22
Asset type
Stock
As filed
Encompass Health Corporation Common Stock
Industry
Medical - Care Facilities · Healthcare

Other trades in this filing

All of McClain's trades →

Recent Congress trades in EHC

Company context for EHC

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. EHCLobbying report·Lobbying disclosures

    EHC: third_quarter 2026 lobbying report

    Medicare inpatient rehabilitation hospital legislative and regulatory proposals; health care and entitlement reform; access to Rehabilition services; essential health benefits under the Affordable Care Act; Medicare post-acute bundling legislation; IRF Proposed Rule; IRF Review Choice Demonstration Proposal.

    Public: Oct 20, 2026, 3:26 PM EDTOriginal source ↗
  2. EHCLobbying report·Lobbying disclosures

    EHC: third_quarter 2026 lobbying report

    Inpatient rehabilitation hospital legislative and regulatory proposals (Medicare); Medicare Advantage program; IRF Review Choice Demonstration. Inpatient rehabilitation hospital legislative and regulatory proposals (Medicare); Medicare Advantage program; IRF Review Choice Demonstration.

    Public: Oct 19, 2026, 10:13 AM EDTOriginal source ↗
  3. EHCLobbying report·Lobbying disclosures

    EHC: second_quarter 2026 lobbying report

    Inpatient rehabilitation hospital legislative and regulatory proposals (Medicare); Medicare Advantage program; IRF Review Choice Demonstration. Inpatient rehabilitation hospital legislative and regulatory proposals (Medicare); Medicare Advantage program; IRF Review Choice Demonstration.

    Public: Jul 20, 2026, 5:00 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.